CAMBRIDGE, Mass.--(BUSINESS WIRE)--GenePeeks, Inc., a computational genomics company focused on transforming genetic disease risk analysis, today announced partnerships with two leading fertility organizations: The Donor Solution, an independent egg donation agency, and 3 Sisters Surrogacy, a gestational carrier service.
Through these partnerships, more prospective parents will have access to GenePeeks’ proprietary preconception genetic screening test, which assesses combined parental risk of passing on more than 1,000 serious genetic diseases. GenePeeks’ comprehensive approach, called Virtual Progeny Analytics (VPA), uniquely integrates simulated DNA information from two genetic participants to predict the future genome of a child prior to conception. For every mutation in these hypothetical genomes, the company computes a proprietary Variant Gene Dysfunction (VGD) score that predicts gene function and associated disease risk. This next generation approach allows GenePeeks to cover an expanded number of diseases with increased sensitivity and evaluate variants that may remain uncharacterized by other genetic tests, while avoiding the confusion and anxiety that can be associated with carrier testing. In contrast to carrier screening, which identifies parental carrier status, GenePeeks focuses on a future child’s true risk of disease inheritance. GenePeeks offers this physician-ordered service through its CLIA certified clinical laboratory.
Over the last ten years, The Donor Solution has helped over 1,000 families to have children, with a success rate of over 82% for first time donors. 3 Sisters Surrogacy provides exceptional support for the increasing number of individuals seeking a gestational carrier to build their family. Clients using the services of either agency will be able to use the GenePeeks test to make more informed reproductive decisions with increased confidence. In addition, The Donor Solution’s donors who have completed the pre-test protocols will be identified as “GenePeeks Ready,” saving prospective parents precious time in their fertility journey.
“We are thrilled to partner with The Donor Solution and 3 Sisters Surrogacy, two organizations that share our unrelenting commitment to provide outstanding support on the complicated path of starting a family,” said Anne Morriss, Co-founder and Chief Executive Officer of GenePeeks. “In addition to reaching more families, these collaborations will allow us to expand our physician network and increase patient access to our next generation technology.”
Mary Fusillo, Founder and Executive Director of The Donor Solution and Chief Executive Officer of 3 Sisters Surrogacy, stated, “At The Donor Solution and 3 Sisters Surrogacy, we are committed to providing our clients with the highest quality care possible. Our partnership with GenePeeks is an important step in ensuring that our intended families can protect the future health of their children with access to the most advanced preconception risk screening available.”
About GenePeeks
GenePeeks is a computational genomics
company focused on identifying inherited disease risk in future
generations. GenePeeks’ patented technology digitally combines the
genetic information of two potential parents, simulating the complex
genetic interactions that occur naturally in human reproduction. The
company’s proprietary platform creates and analyzes thousands of Virtual
Progeny to uncover disease risk that cannot be seen with alternative
screening tools. GenePeeks offers this physician-ordered service through
its CLIA certified clinical laboratory.
GenePeeks is privately held, with corporate offices in Cambridge, Mass. For more information, visit www.genepeeks.com.
GenePeeks’ next-generation screening technology is available today. For more information about becoming a partner, please contact support@genepeeks.com.
About The Donor Solution
The Donor Solution is a leading egg
donor agency in the southwest United States. Known for providing
exceptional egg donors, the agency recruits outstanding young women for
their program. Founded in 2007 by Mary M. Fusillo, RN, BSN, MS, the
agency has helped over 1,000 couples reach their goal of becoming
parents. With over 25 years of nursing and hospital management
experience, Mary and her team are committed to reducing the stress of
the fertility journey while delivering the highest standard of care to
both donors and recipients. The organization has offices in Houston and
Dallas, Texas and Phoenix, Arizona, with satellite offices in Austin,
Texas and Los Angeles/Beverly Hills, California. For more information,
visit thedonorsolution.com.
About 3 Sisters Surrogacy
3 Sisters Surrogacy is a
gestational carrier program dedicated to providing intended parents with
the highest level of competence and professionalism. Chief Executive
Officer Mary M. Fusillo, RN, BSN, MS has over 16 years of third party
parenting experience and donor recruitment, and Chief Scientific Officer
Sunday Crider, Ph.D., has worked for 13 years as an IVF embryologist and
laboratory director. This combined experience is unique in the industry
and has allowed the organization to provide the highest standard of
service to all clients. Corporate offices are located in Houston, Texas,
with satellite offices in Dallas, Texas and Phoenix, Arizona. For more
information, visit 3sisterssurrogacy.com.
